Company intelligence / Profile preview
Te Arai BioFarma
New Zealandtearaibiofarma.co.nz ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Te Arai BioFarma is a privately owned company specializing in medical devices and specialty medicines. Recent financial data shows a 14% increase in revenues in Q4 2024 compared to Q4 2023, with a 3% improvement in gross profit margin for FY 2024 compared to FY 2023, and an 18% improvement in net loss in Q4 2024[9].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Medical devicesSpecialty medicinesBiological medicines
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Sonoma Pharmaceuticals
Beyond the preview
Go deeper on Te Arai BioFarma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Te Arai BioFarma.